
Vaccination Rates Skyrocket for Preteens, But Disparities Remain
2025-07-08
Author: Li
New Study Highlights the Impact of Parental Engagement on HPV Vaccination Rates
A groundbreaking study from the Mayo Clinic has uncovered that preteens are far more likely to get vaccinated against human papillomavirus (HPV) when their parents receive reminder letters and when their healthcare providers have access to vaccination data. However, the success of this intervention is notably less effective within the most disadvantaged communities.
Key Findings from the Research
Published in JAMA Network Open, this study analyzed data from a trial involving over 6,200 children aged 11 to 12 years, conducted from April 2018 to August 2022 across six primary-care practices in Minnesota. The results indicated a significant boost in initiation of the HPV vaccine due to these proactive measures.
Dramatic Increase But Not for Everyone
Approximately 72.2% of participants identified as White, followed by 9.0% Black, 4.9% Asian, and 2.3% Hispanic. While the intervention led to a considerable increase in vaccination initiation rates (between 9.2% to 24.0%), this boost wasn’t as pronounced among Black children, those in rural areas, or families from economically disadvantaged backgrounds.
The Urgent Need for Alternative Strategies
Despite the HPV vaccine's proven safety and widespread accessibility, HPV vaccination coverage in the U.S. remains disappointing at just 50%, far from the national goal of 80%, with high-risk HPV infections linked to around 37,000 new cancer cases each year.
Call to Action for Future Research
The researchers emphasized the necessity for further exploration into different intervention strategies that can effectively engage families from socioeconomically disadvantaged areas, thereby addressing and reducing existing disparities in HPV vaccination rates.
Conclusion: Bridging the Gap
As the research shows, merely sending reminder letters is not enough, especially in marginalized communities. There is an urgent need to develop targeted strategies that ensure all children, regardless of their background, have equal access to lifesaving vaccines.